PKM and central nervous system cancer: In glioma cells, it was first observed that PKM2, when phosphorylated by activated EGFR, translocates to the nucleus and interacts with histone H3, inducing H3 threonine 11 (T11) phosphorylation and promoting lysine 9 (K9) acetylation.